MedTrace Logo

Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval

NCT03458143 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-03-13

No results posted yet for this study

Summary

This study evaluates the effect of the addition of ketamine to a conscious sedation protocol including remifentanil during oocyte retrieval. The investigators will have 2 groups with different target effect site concentrations, namely 150 ng/ml and 200 ng/ml.

Conditions

  • Oocyte Retrieval
  • Sedation, Conscious
  • Ventilatory Depression

Interventions

DRUG

Ketamine 150 ng/ml

conscious sedation in TCI-mode

DRUG

Remifentanil

conscious sedation in TCI-mode

PROCEDURE

Oocyte retrieval

Oocyte retrieval for In Vitro Fertilization

DRUG

Ketamine 200 ng/ml

conscious sedation in TCI-mode

Sponsors & Collaborators

  • Erasme University Hospital

    lead OTHER

Principal Investigators

  • Peres-Bota Iulia, student · Erasme hospital

  • Barvais Luc, MDPhD · Erasme hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-12
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03458143 on ClinicalTrials.gov